Podrobný výpis o publikaci

SCHUTZ, Katharina, Diana ALECSANDRU, Bodo GRIMBACHER, Jamanda HADDOCK, Annemarie BRUINING, Gertjan DRIESSEN, Esther DE VRIES, Peter M. VAN HAGEN, Ieneke HARTMANN, Francesco FRAIOLI, Cinzia MILITO, Milica MITREVSKI, Isabella QUINTI, Goffredo SERRA, Peter KELLEHER, Michael LOEBINGER, Jiří LITZMAN, Věra POSTRÁNECKÁ, Vojtěch THON, Judith BABAR, Alison M. CONDLIFFE, Andrew EXLEY, Dinakantha KUMARARATNE, Nick SCREATON, Alison JONES, Maria P. BONDIONI, Vassilios LOUGARIS, Alessandro PLEBANI, Annarosa SORESINA, Cesare SIRIGNANO, Giuseppe SPADARO, Nermeen GALAL, Luis I. GONZALEZ-GRANADO, Sabine DETTMER, Robert STIRLING, Helen CHAPEL, Mary LUCAS, Smita PATEL, Claire-Michele FARBER, Isabelle MEYTS, Arpan K. BANERJEE, Scott HACKETT, John R. HURST, Klaus WARNATZ, Benjamin GATHMANN a Ulrich BAUMANN. Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group. Journal of Clinical Immunology. New York: Springer, 2019, roč. 39, č. 1, s. 45-54. ISSN 0271-9142. Dostupné z: https://dx.doi.org/10.1007/s10875-018-0577-9.

Další formáty: BibTeX LaTeX RIS

TY  - JOUR
ID  - 1549656
AU  - Schutz, Katharina - Alecsandru, Diana - Grimbacher, Bodo - Haddock, Jamanda - Bruining, Annemarie - Driessen, Gertjan - de Vries, Esther - van Hagen, Peter M. - Hartmann, Ieneke - Fraioli, Francesco - Milito, Cinzia - Mitrevski, Milica - Quinti, Isabella - Serra, Goffredo - Kelleher, Peter - Loebinger, Michael - Litzman, Jiří - Postránecká, Věra - Thon, Vojtěch - Babar, Judith - Condliffe, Alison M. - Exley, Andrew - Kumararatne, Dinakantha - Screaton, Nick - Jones, Alison - Bondioni, Maria P. - Lougaris, Vassilios - Plebani, Alessandro - Soresina, Annarosa - Sirignano, Cesare - Spadaro, Giuseppe - Galal, Nermeen - Gonzalez-Granado, Luis I. - Dettmer, Sabine - Stirling, Robert - Chapel, Helen - Lucas, Mary - Patel, Smita - Farber, Claire-Michele - Meyts, Isabelle - Banerjee, Arpan K. - Hackett, Scott - Hurst, John R. - Warnatz, Klaus - Gathmann, Benjamin - Baumann, Ulrich
PY  - 2019
TI  - Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group
JF  - Journal of Clinical Immunology
VL  - 39
IS  - 1
SP  - 45-54
EP  - 45-54
PB  - Springer
SN  - 02719142
KW  - Chest CT
KW  - CVID
KW  - primary antibody deficiency
KW  - bronchiectasis
KW  - bronchial pathology
UR  - https://link.springer.com/article/10.1007%2Fs10875-018-0577-9
L2  - https://link.springer.com/article/10.1007%2Fs10875-018-0577-9
N2  - Studies of chest computed tomography (CT) in patients with primary antibody deficiency syndromes (ADS) suggest a broad range of bronchial pathology. However, there are as yet no multicentre studies to assess the variety of bronchial pathology in this patient group. One of the underlying reasons is the lack of a consensus methodology, a prerequisite to jointly document chest CT findings. We aimed to establish an international platform for the evaluation of bronchial pathology as assessed by chest CT and to describe the range of bronchial pathologies in patients with antibody deficiency. Ffteen immunodeficiency centres from 9 countries evaluated chest CT scans of patients with ADS using a predefined list of potential findings including an extent score for bronchiectasis. Data of 282 patients with ADS were collected. Patients with common variable immunodeficiency disorders (CVID) comprised the largest subgroup (232 patients, 82.3%). Eighty percent of CVID patients had radiological evidence of bronchial pathology including bronchiectasis in 61%, bronchial wall thickening in 44% and mucus plugging in 29%. Bronchiectasis was detected in 44% of CVID patients aged less than 20years. Cough was a better predictor for bronchiectasis than spirometry values. Delay of diagnosis as well as duration of disease correlated positively with presence of bronchiectasis. The use of consensus diagnostic criteria and a pre-defined list of bronchial pathologies allows for comparison of chest CT data in multicentre studies. Our data suggest a high prevalence of bronchial pathology in CVID due to late diagnosis or duration of disease.
ER  -

Základní údaje
Originální název	Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group
Autoři	SCHUTZ, Katharina (276 Německo), Diana ALECSANDRU (826 Velká Británie a Severní Irsko), Bodo GRIMBACHER (276 Německo), Jamanda HADDOCK (826 Velká Británie a Severní Irsko), Annemarie BRUINING (528 Nizozemské království), Gertjan DRIESSEN (528 Nizozemské království), Esther DE VRIES (528 Nizozemské království), Peter M. VAN HAGEN, Ieneke HARTMANN (528 Nizozemské království), Francesco FRAIOLI (380 Itálie), Cinzia MILITO (380 Itálie), Milica MITREVSKI (380 Itálie), Isabella QUINTI (380 Itálie), Goffredo SERRA (380 Itálie), Peter KELLEHER (826 Velká Británie a Severní Irsko), Michael LOEBINGER (826 Velká Británie a Severní Irsko), Jiří LITZMAN (203 Česká republika, domácí), Věra POSTRÁNECKÁ (203 Česká republika), Vojtěch THON (203 Česká republika, garant, domácí), Judith BABAR (826 Velká Británie a Severní Irsko), Alison M. CONDLIFFE (826 Velká Británie a Severní Irsko), Andrew EXLEY (826 Velká Británie a Severní Irsko), Dinakantha KUMARARATNE (826 Velká Británie a Severní Irsko), Nick SCREATON (826 Velká Británie a Severní Irsko), Alison JONES (826 Velká Británie a Severní Irsko), Maria P. BONDIONI (380 Itálie), Vassilios LOUGARIS (380 Itálie), Alessandro PLEBANI (380 Itálie), Annarosa SORESINA (380 Itálie), Cesare SIRIGNANO (380 Itálie), Giuseppe SPADARO (380 Itálie), Nermeen GALAL (818 Egypt), Luis I. GONZALEZ-GRANADO (724 Španělsko), Sabine DETTMER (276 Německo), Robert STIRLING (36 Austrálie), Helen CHAPEL (826 Velká Británie a Severní Irsko), Mary LUCAS (826 Velká Británie a Severní Irsko), Smita PATEL (826 Velká Británie a Severní Irsko), Claire-Michele FARBER (56 Belgie), Isabelle MEYTS (56 Belgie), Arpan K. BANERJEE (826 Velká Británie a Severní Irsko), Scott HACKETT (826 Velká Británie a Severní Irsko), John R. HURST (826 Velká Británie a Severní Irsko), Klaus WARNATZ (276 Německo), Benjamin GATHMANN (276 Německo) a Ulrich BAUMANN (276 Německo).
Vydání	Journal of Clinical Immunology, New York, Springer, 2019, 0271-9142.

Další údaje
Originální jazyk	angličtina
Typ výsledku	Článek v odborném periodiku
Obor	30102 Immunology
Stát vydavatele	Spojené státy
Utajení	není předmětem státního či obchodního tajemství
WWW	URL
Impakt faktor	Impact factor: 6.780
Kód RIV	RIV/00216224:14110/19:00110433
Organizační jednotka	Lékařská fakulta
Doi	http://dx.doi.org/10.1007/s10875-018-0577-9
UT WoS	000458867500011
Klíčová slova anglicky	Chest CT; CVID; primary antibody deficiency; bronchiectasis; bronchial pathology
Štítky	14110114, podil, rivok
Příznaky	Mezinárodní význam, Recenzováno
Změnil	Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 21. 1. 2020 07:03.

Anotace
Studies of chest computed tomography (CT) in patients with primary antibody deficiency syndromes (ADS) suggest a broad range of bronchial pathology. However, there are as yet no multicentre studies to assess the variety of bronchial pathology in this patient group. One of the underlying reasons is the lack of a consensus methodology, a prerequisite to jointly document chest CT findings. We aimed to establish an international platform for the evaluation of bronchial pathology as assessed by chest CT and to describe the range of bronchial pathologies in patients with antibody deficiency. Ffteen immunodeficiency centres from 9 countries evaluated chest CT scans of patients with ADS using a predefined list of potential findings including an extent score for bronchiectasis. Data of 282 patients with ADS were collected. Patients with common variable immunodeficiency disorders (CVID) comprised the largest subgroup (232 patients, 82.3%). Eighty percent of CVID patients had radiological evidence of bronchial pathology including bronchiectasis in 61%, bronchial wall thickening in 44% and mucus plugging in 29%. Bronchiectasis was detected in 44% of CVID patients aged less than 20years. Cough was a better predictor for bronchiectasis than spirometry values. Delay of diagnosis as well as duration of disease correlated positively with presence of bronchiectasis. The use of consensus diagnostic criteria and a pre-defined list of bronchial pathologies allows for comparison of chest CT data in multicentre studies. Our data suggest a high prevalence of bronchial pathology in CVID due to late diagnosis or duration of disease.

Anotace

Studies of chest computed tomography (CT) in patients with primary antibody deficiency syndromes (ADS) suggest a broad range of bronchial pathology. However, there are as yet no multicentre studies to assess the variety of bronchial pathology in this patient group. One of the underlying reasons is the lack of a consensus methodology, a prerequisite to jointly document chest CT findings. We aimed to establish an international platform for the evaluation of bronchial pathology as assessed by chest CT and to describe the range of bronchial pathologies in patients with antibody deficiency. Ffteen immunodeficiency centres from 9 countries evaluated chest CT scans of patients with ADS using a predefined list of potential findings including an extent score for bronchiectasis. Data of 282 patients with ADS were collected. Patients with common variable immunodeficiency disorders (CVID) comprised the largest subgroup (232 patients, 82.3%). Eighty percent of CVID patients had radiological evidence of bronchial pathology including bronchiectasis in 61%, bronchial wall thickening in 44% and mucus plugging in 29%. Bronchiectasis was detected in 44% of CVID patients aged less than 20years. Cough was a better predictor for bronchiectasis than spirometry values. Delay of diagnosis as well as duration of disease correlated positively with presence of bronchiectasis. The use of consensus diagnostic criteria and a pre-defined list of bronchial pathologies allows for comparison of chest CT data in multicentre studies. Our data suggest a high prevalence of bronchial pathology in CVID due to late diagnosis or duration of disease.

Návaznosti
EF15_003/0000469, projekt VaV	Název: Cetocoen Plus